NextCell Presents Quarterly Report

NextCell Pharma AB ("NextCell" or the "Company") invites investors, analysts and media to an investor presentation in conjunction with the publication of the Company's second interim report for the 2024/2025 financial year, on Thursday, 25 April 2025.

CEO Mathias Svahn will present the Company, the report, and the results from the subgroup analysis published on 7 April 2025. The Company’s subsidiaries, Cellaviva and QVance, will also be presented by their respective CEOs: Sofie Falk Jansson (Cellaviva) and Lindsay Davies (QVance). Attendees, both on-site and online, will have the opportunity to ask questions. The presentation will be available for on-demand streaming.

Time: Friday, 25 April 2025, at 2:00 PM

Venue: Redeye, Mäster Samuelsgatan 42, Stockholm, Sweden

Registration (for on-site attendance): Please register by email to [email protected]

Webcast (no pre-registration required): Please follow this link:

https://www.redeye.se/events/1095576/business-update-nextcell-pharma